Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSKIRA-ABPM: Fostamatinib in Rheumatoid Arthritis
NCT01563978Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of fostamatinib in rheumatoid arthritis (RA), sponsored by AstraZeneca. Started Apr 2012; status: completed.
02
Drugs
fostamatinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01563978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563978.